The purpose of this legislation, known as the American Innovation and R&D Competitiveness Act of 2025, is to amend the Internal Revenue Code to restore the ability for businesses to deduct research and experimental expenditures from their taxable income. This aims to encourage innovation and support companies engaged in research and development activities. The key provisions of the legislation allow taxpayers to treat certain research and experimental expenditures as immediate expenses rather than capital investments.